Le Lézard
Classified in: Health
Subjects: PER, SCZ, DEI

Watercrest Senior Living Group Welcomes Marsha Sottung as Executive Director of Watercrest Richmond Assisted Living and Memory Care


VERO BEACH, Fla., Sept. 7, 2022 /PRNewswire/ -- Watercrest Senior Living Group proudly announces Marsha Sottung as Executive Director of Watercrest Richmond Assisted Living and Memory Care in Moseley, Virginia. Watercrest Richmond is currently under construction and preparing to welcome residents this fall to the 98-unit luxury senior living community.

Sottung realized her passion for the senior living industry at an early age, becoming the youngest assisted living administrator in the state of New York at the age of 21.  For the past thirty years, she has focused on serving seniors with dignity and respect in her various roles as a certified nursing aide, operations director, and regional manager.  As Executive Director of Watercrest Richmond, Sottung brings a wealth of experience alongside her certifications as a Certified Dementia Practitioner, Assisted Living Preceptor, and Assisted Living Administrator.

"Marsha passionately cares for seniors with a servant heart and commitment to excellence in all aspects of her role as a leader, mentor, confidante, and team builder," says Marc Vorkapich, principal and CEO of Watercrest Senior Living Group. "We look forward to her continued growth and success within our Watercrest family."

Watercrest Richmond will be a signature Watercrest product offering 76 assisted living and 22 memory care apartments with resort-style amenities and exceptional care.  The architecture and design will boast a stunning fountain and promenade, art studio with gallery, music room, fireplace, multiple dining venues, theater, salon and spa, and the charming atmosphere of Bogey's Cigar and Scotch lounge.  Watercrest Richmond is conveniently located at 5250 Grandin Avenue in Moseley. For information or to schedule a tour, contact the community at 804-294-3508.

Watercrest principals, Marc Vorkapich, CEO and Joan Williams, CFO, are setting new standards of quality for seniors and their families in the development of upscale senior living communities from South Florida to Virginia.  This is the first senior living development project partnered between Watercrest and Harbert Seniors Housing Fund II.

About Harbert Management Corporation

HMC is an investment management firm focusing on alternative assets, with approximately $8.0 billion in Regulatory Assets under Management as of November 30, 2021. A privately owned firm founded in 1993, HMC serves foundations, endowments, fund of funds, pension funds, financial institutions, insurance companies, family offices, and high net worth individuals across multiple asset classes. For additional information about HMC, visit www.harbert.net.

About Watercrest Senior Living Group

Watercrest Senior Living Group was founded to honor our mothers and fathers, aspiring to become a beacon for quality in senior living by surpassing standards of care, service and associate training. Watercrest communities are recognized for their luxury aesthetic, exceptional amenities, world-class care, and innovative memory care programming offering unparalleled service to seniors living with Alzheimer's and dementia. A certified Great Place to Work, Watercrest specializes in the development and operations of assisted living and memory care communities and the growth of servant leaders.  For information, visit www.watercrestseniorliving.com

SOURCE Watercrest Senior Living Group


These press releases may also interest you

at 01:18
. Hansa Biopharma, "Hansa" (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant Congress (ATC), the joint annual meeting of the American Society of Transplant Surgeons (ASTS) and the American...

at 01:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an investigational oral therapy, in combination with...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by...

at 00:01
Celltrion USA announced today...

at 00:01
SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) ? defined as people living with ulcerative colitis or Crohn's...

at 00:00
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it signed a memorandum of understanding with YASKAWA Electric Corporation (YASKAWA) to begin discussions on the creation of an innovative cell therapy...



News published on and distributed by: